-

Auditing and Qualifying Suppliers and Vendors: An Effective Risk-based Approach Training Course (Mar 3rd - Mar 5th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Auditing and Qualifying Suppliers and Vendors: An Effective Risk-based Approach (Mar 3rd - Mar 5th, 2026)" training has been added to ResearchAndMarkets.com's offering.

Supplier or vendor qualification is a crucial component in compliance to 21 CFR 111. The FDA requires that manufacturers of dietary supplements, Pharmaceuticals, Biotech and Medical Device must "qualify" each of their vendors but do not provide guidance on how a company is to perform this qualification. Supplier qualification principles also apply to subcontracted services affecting cGMP (manufacturingsteps, packaging and labeling, testing and/or calibration services, storage and distribution, etc.) Any supplier qualification program must include two critical components:

  • Clearly defined specifications/requirements for all of these goods or services being purchased, and;
  • Objective evidence to show that your requirements are being consistently fulfilled.

It is designed for those who already have a basic understanding of dietary supplement GMPs and the knowledge and skills necessary to qualify suppliers.

Since the evaluation of all types of suppliers often involves auditing, this course will incorporate a fresh look at the auditing process and the skills and techniques needed to get the most from these activities. The skills and techniques learned are independent of the type of auditing or the standard being audited and will be useful when conducting internal audits and performing audits of suppliers.

Why Should You Attend

The various regulatory agencies have expectations that suppliers and vendors will demonstrate control over their manufacturing processes, validations, and documentation. Quality auditing is the process of checking whether these organizations have implemented what they have stated in written procedures and whether their people are doing what the organizations procedures state they will do.

Learning Objectives

On conclusion of this course, you will have an understanding of the following:

  • Regulations that apply to vendor qualification (21 CFR 111)
  • Food Safety Modernization Act (FSMA)
  • Impact of FSMA on Supplier Qualification
  • Risk assessment and risk management
  • Supplier monitoring activities
  • On-site audit strategies and requirements
  • Managing the audit process effectively before, during and after
  • The consequences of non-compliance

This live training Seminar includes the following for each registered attendee:

  • A copy of the presentation slides by download
  • A certificate of participation for attendee training records
  • Q/A Session
  • Free Handouts on FDA Inspection

Who Should Attend:

This intensive, practical course will be of value to those professionals in the pharmaceutical, medical device and related industries who are responsible for or involved in any interaction with suppliers, including those working in:

  • Management
  • Laboratories
  • Auditing
  • Purchasing
  • QA/QC
  • Procurement
  • R&D
  • Legal
  • Manufacturing
  • Validation
  • Regulatory Affairs
  • Documentation Management

Key Topics Covered:

Topic 1: The Benefits of Effective Supplier Management

  • Key Components of a Supplier Management Program

Topic 2: Regulatory Guidance Review

  • Understanding Regulatory Requirements and Standards for Supplier and Contract
  • Manufacturer (CM) Management:
    • United States Food and Drug Association (FDA) regulations and guidance
    • European Union (EU) directives and guidelines
    • International Standardization Association (ISO) standards
    • Examples of regulatory findings

Topic 3: The Cost of Poor Quality from Suppliers and CMs:

  • How to speak management's language

Topic 4: Strategic Management of Suppliers:

  • Developing a strategic plan based on your company and environment
  • Risk Management - A Lifecycle Approach:
  • Template for a risk assessment

Topic 5: Supplier qualification

  • Selecting a Supplier or Contract Manufacturer
  • Obtaining information on suppliers
  • Tools for making the selection
    • Supplier Assessments:
    • Desktop assessments
    • Supplier audits
    • Handling Supplier Transitions
  • How to use your strategic plan to make decisions
  • When to use a sole source supplier
  • Building a Relationships with a Supplier or Contract Manufacturer
  • Making your Supplier Quality Agreement a Great Resource:
    • Quality Agreement Template
  • Monitoring Your Supplier's Performance to Reduce Risks and Costs:
    • Template for a supplier scorecard
  • Managing nonconforming events
  • Partnering with a Supplier or CM for Improvement:
    • Tools for improvement

Speakers:

Kelly Thomas
Vice President
Stallergenes Greer

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

For more information about this training visit https://www.researchandmarkets.com/r/hiyueq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 - Subcutaneous Route to Command Over 65% Share - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peptide Therapeutics Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Peptide, Route of Administration, Key Therapeutic Area and Geographical Regions" has been added to ResearchAndMarkets.com's offering. The peptide therapeutics market is poised for significant growth, projected to escalate from USD 84.2 billion in 2023 to USD 162.4 billion by 2035, marking a CAGR of 6.8%. These therapeutics, built from polypeptides, are increasingl...

Cambodia Spirits Market Report 2025-2031 Featuring Profiles of Seekers Independent Spirits Co., Samai Distillery Cambodia, Diageo, Holly Creek Whisky Co., Pernod Ricard and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cambodia Spirits Market 2025-2031" has been added to ResearchAndMarkets.com's offering. Between 2021 and 2024, the Cambodian spirits market observed robust growth, bolstered by evolving consumer preferences, greater disposable incomes, and a burgeoning young, urbanized populace. Spirits such as whiskey, rum, and vodka experienced increased demand due to lifestyle changes, social events, and a thriving tourism sector, which flourished in 2024 compared to 2022. Gover...

Metal and Lipid Nanoparticle Manufacturing Market Intelligence Report 2025-2035 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Metal and Lipid Nanoparticle Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Service, Company Size, Type of Nanoparticles Manufactured, Scale of Operation, Type of End User and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering. The metal and lipid nanoparticle manufacturing market is currently valued at USD 2.1 billion, projected to grow at a CAGR of 8.6% until 2035. This growth is driven b...
Back to Newsroom